By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


iBio, Inc. 

9 Innovation Way
Suite 100
Newark  Delaware  19711  U.S.A.
Phone: 302-355-0650 Fax: 302-356-1173


Company News
Warren Ribley Named President & CEO Of iBio, Inc. (IBIO) And The iBIO Institute 1/7/2015 9:43:32 AM
iBio, Inc. (IBIO) Provides Updates On Its IBIO-CFB03 Fibrosis Drug Candidate And Other Activities For The 2014 Annual Shareholders Meeting 12/12/2014 11:09:14 AM
iBio, Inc. (IBIO) Grants Caliber Biotherapeutics License For Production Of Antibodies Targeting Ebola 11/10/2014 10:05:35 AM
iBio, Inc. (IBIO) Expands Exclusive Product Collaboration With Novici Biotech 10/22/2014 1:18:04 PM
iBio, Inc. (IBIO) Responds To Inquiries About Its Role In Emergency Response To Ebola Virus Disease Outbreak 10/17/2014 12:38:00 PM
iBio, Inc. (IBIO) Reports On Filing Of 2014 Annual Report 10/6/2014 11:02:27 AM
Dr. Thomas A. Medsger Jr. Joins iBio, Inc. (IBIO) Clinical Advisory Board 9/3/2014 2:35:31 PM
iBio, Inc. (IBIO) Receives European Patent Allowances For Protein Expression Technology 8/28/2014 12:11:24 PM
iBio, Inc. (IBIO) Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital 8/26/2014 10:38:22 AM
iBio, Inc. (IBIO) Appoints Another IPF Expert, Dr. J. Terrill Huggins, To Clinical Advisory Board 8/1/2014 11:18:51 AM